Correction to inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer

IF 4.5 2区医学 Q1 ONCOLOGY

Cancer Science Pub Date : 2024-07-23 DOI:10.1111/cas.16291

引用次数: 0

Abstract

Yan Kuang, Hong Xu, Fangfang Lu, Jiahua Meng, Yeye Yi, Huilan Yang, Hairui Hou, Hao Wei, Shanheng Su. Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer. Cancer Science. 2021;112:231–242.

We apologize for these errors.

Abstract Image

查看原文本刊更多论文

KDM2B 对抑制 microRNA let-7b 表达的纠正通过靶向卵巢癌中的 EZH2 促进癌症进展。

匡艳徐红卢芳芳孟佳华易烨杨慧兰侯海瑞魏浩苏善恒KDM2B靶向EZH2抑制卵巢癌microRNA let-7b表达促进癌症进展癌症科学2021;112:231-242.We apologize for these errors.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Science 医学-肿瘤学

自引率

3.50%

发文量

406

审稿时长

2 months

期刊介绍： Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports. Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.